TY - JOUR
T1 - Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction
AU - Gori, Mauro
AU - Senni, Michele
AU - Gupta, Deepak K.
AU - Charytan, David M.
AU - Kraigher-Krainer, Elisabeth
AU - Pieske, Burkert
AU - Claggett, Brian
AU - Shah, Amil M.
AU - Santos, Angela B S
AU - Zile, Michael R.
AU - Voors, Adriaan A.
AU - McMurray, John J V
AU - Packer, Milton
AU - Bransford, Toni
AU - Lefkowitz, Martin
AU - Solomon, Scott D.
N1 - Funding Information:
This study was funded by Novartis Pharmaceuticals, East Hanover, NJ, USA.
Publisher Copyright:
© 2014 Published on behalf of the European Society of Cardiology.
PY - 2014/12/21
Y1 - 2014/12/21
N2 - Aim Renal dysfunction is a common comorbidity in patients with heart failure and preserved ejection fraction (HFpEF). We sought to determine whether renal dysfunction was associated with measures of cardiovascular structure/function in patients with HFpEF. Methods We studied 217 participants from the PARAMOUNT study with HFpEF who had echocardiography and measures of kidney function. We evaluated the relationships between renal dysfunction [estimated glomerular filtration rate (eGFR) >30 and <60 mL/min/1.73 m2 and/or albuminuria] and cardiovascular structure/function. Results The mean age of the study population was 71 years, 55% were women, 94% hypertensive, and 40% diabetic. Impairment of at least one parameter of kidney function was present in 62% of patients (16% only albuminuria, 23% only low eGFR, 23% both). Renal dysfunction was associated with abnormal LV geometry (defined as concentric hypertrophy, or eccentric hypertrophy, or concentric remodelling) (adjusted P = 0.048), lower midwall fractional shortening (MWFS) (P = 0.009), and higher NT-proBNP (P = 0.006). Compared with patients without renal dysfunction, those with low eGFR and no albuminuria had a higher prevalence of abnormal LV geometry (P = 0.032) and lower MWFS (P < 0.01), as opposed to those with only albuminuria. Conversely, albuminuria alone was associated with greater LV dimensions (P < 0.05). Patients with combined renal impairment had mixed abnormalities (higher LV wall thicknesses, NT-proBNP; lower MWFS). Conclusion Renal dysfunction, as determined by both eGFR and albuminuria, is highly prevalent in HFpEF, and associated with cardiac remodelling and subtle systolic dysfunction. The observed differences in cardiac structure/function between each type of renal damage suggest that both parameters of kidney function might play a distinct role in HFpEF.
AB - Aim Renal dysfunction is a common comorbidity in patients with heart failure and preserved ejection fraction (HFpEF). We sought to determine whether renal dysfunction was associated with measures of cardiovascular structure/function in patients with HFpEF. Methods We studied 217 participants from the PARAMOUNT study with HFpEF who had echocardiography and measures of kidney function. We evaluated the relationships between renal dysfunction [estimated glomerular filtration rate (eGFR) >30 and <60 mL/min/1.73 m2 and/or albuminuria] and cardiovascular structure/function. Results The mean age of the study population was 71 years, 55% were women, 94% hypertensive, and 40% diabetic. Impairment of at least one parameter of kidney function was present in 62% of patients (16% only albuminuria, 23% only low eGFR, 23% both). Renal dysfunction was associated with abnormal LV geometry (defined as concentric hypertrophy, or eccentric hypertrophy, or concentric remodelling) (adjusted P = 0.048), lower midwall fractional shortening (MWFS) (P = 0.009), and higher NT-proBNP (P = 0.006). Compared with patients without renal dysfunction, those with low eGFR and no albuminuria had a higher prevalence of abnormal LV geometry (P = 0.032) and lower MWFS (P < 0.01), as opposed to those with only albuminuria. Conversely, albuminuria alone was associated with greater LV dimensions (P < 0.05). Patients with combined renal impairment had mixed abnormalities (higher LV wall thicknesses, NT-proBNP; lower MWFS). Conclusion Renal dysfunction, as determined by both eGFR and albuminuria, is highly prevalent in HFpEF, and associated with cardiac remodelling and subtle systolic dysfunction. The observed differences in cardiac structure/function between each type of renal damage suggest that both parameters of kidney function might play a distinct role in HFpEF.
KW - Albuminuria
KW - Cardiovascular structure and function
KW - Chronic kidney disease
KW - Glomerular filtration rate
KW - Heart failure with preserved ejection fraction
UR - http://www.scopus.com/inward/record.url?scp=84924264610&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84924264610&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehu254
DO - 10.1093/eurheartj/ehu254
M3 - Article
C2 - 24980489
AN - SCOPUS:84924264610
SN - 0195-668X
VL - 35
SP - 3442
EP - 3451
JO - European Heart Journal
JF - European Heart Journal
IS - 48
ER -